Drug intelligence / Profile preview

Guilutianjing Capsules

Development stage: Unknown
Lead developer: Hospital of Chengdu University of Traditional Chinese Medicine
Administration: Oral

Overview

Guilutianjing Capsules (also referred to as Guilu Tianjing) is a Traditional Chinese Medicine (TCM) formulation developed by the Hospital of Chengdu University of Traditional Chinese Medicine. It is designed based on the TCM theory of 'kidney master reproduction' to treat male infertility, specifically asthenozoospermia associated with kidney-yang deficiency. The drug is currently being evaluated in Phase 2 clinical trials in China, where its efficacy in improving sperm parameters is compared against the standard TCM treatment, Wu Zi Yan Zong Pill, over a 90-day treatment course.

Brand names: Guilutianjing Capsules
Other names: Guilu Tianjing CapsulesGuilu Tianjing Jiao Nang

Beyond the preview

Go deeper on Guilutianjing Capsules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guilutianjing Capsules.

Explore the full profile